Will BLDR's FY2026 Adjusted EBITDA exceed the midpoint of guidance ($1.5B)?

FY2026 EBITDA guidance is $1.3-1.7B with midpoint at $1.5B. The $1.5B threshold sits at the exact midpoint of management's own range — meaning management itself sees roughly equal odds above and below. However, the Q4 2025 miss (sales decelerated more than expected) and the continued housing weakness suggest downside risk is greater than upside. The $100M cost actions provide support but may be offset by volume declines. Commodity assumption of $365-385/mbf is reasonable but further deflation is possible.

The guidance midpoint implies flat starts, $365-385/mbf commodity prices, and 28.5-30% gross margins. Any of these assumptions could break negative: starts could decline further, commodities could fall below $365, and margins could compress toward 28.5%. The Q4 EBITDA of $275M (-44% YoY) shows the magnitude of downturn impact. For FY2026 to hit $1.5B requires consistent improvement from Q4's $275M run-rate. The $100M cost actions help but the Myth Meter flagged that the normalized framework may create anchoring bias.

Management set the guidance range after the Q4 miss, so $1.3-1.7B already incorporates the weaker environment. The post-miss conservatism effect (management sandbagging after being burned) could mean the midpoint is beatable. The H2 2026 seasonality should be stronger than H1. Cost actions ($100M SG&A) are mostly already in place per CFO. If housing markets stabilize rather than deteriorate further, the midpoint is achievable. Near coin-flip with slight downward bias.

The housing market outlook is the swing variable and the committee consensus is bearish on near-term recovery. Economists are divided, builders are cautious, and affordability remains challenging. EBITDA at the guidance midpoint requires housing conditions no worse than current — which is not guaranteed. The wide guidance range ($400M) reflects high uncertainty. Below midpoint is moderately more likely given the momentum from Q4 weakness.

The $100M cost action program is the key bullish factor — $75M in actual reductions already being implemented. This provides a floor even if revenue weakens. The productivity savings ($48M) add further support. But EBITDA margin guided at 8.8-10.8% (midpoint 9.8%) compared to Q4's 8.2% requires margin improvement, not just cost cuts. This improvement depends on revenue stabilizing and mix holding. Slightly below coin-flip.

The normalized EBITDA framework ($2.1-2.4B) creates a narrative that current earnings are depressed — but this could blind investors to further downside. The Myth Meter's DIVERGING narrative gap is relevant here. FY2025 EBITDA was ~$1.5B and FY2026 guidance midpoint is the same — implying flat at best in a still-weak market. If the market deteriorates further (as Q4 suggested), below midpoint is the base case.

Midpoint is exact 50/50 by management's assessment, but Q4 weakness and housing headwinds tilt slightly below. Cost actions provide support. Near coin-flip, slightly below.

Housing weakness, commodity deflation, and value-per-start decline all create EBITDA headwinds. $100M cost actions help but may not fully offset. Below midpoint is slightly more probable.

Post-miss guidance conservatism is the strongest bullish signal. Management was burned in Q4 and may have sandbbagged the FY2026 midpoint. If housing merely stabilizes (doesn't recover), midpoint could be achievable. But stabilization is not guaranteed. Slightly below coin-flip.